Sign In

Login

Password

Forgot Password ? Sign Up

Zespół hemolityczno-mocznicowy (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zespół hemolityczno-mocznicowy" in Polish language version.

refsWebsite
Global rank Polish rank
37nih.gov
4th place
7th place
25doi.org
2nd place
6th place
4worldcat.org
5th place
2nd place
1web.archive.org
1st place
1st place
1icm.edu.pl
2,656th place
65th place
1czytelniamedyczna.pl
low place
1,047th place

czytelniamedyczna.pl

doi.org

doi.org

  • C. Loirat, V. Frémeaux-Bacchi. Atypical hemolytic uremic syndrome.. „Orphanet J Rare Dis”. 6, s. 60, 2011. DOI: 10.1186/1750-1172-6-60. PMID: 21902819. 
  • SH. Park, GS. Kim. Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.. „Korean J Anesthesiol”. 66 (6), s. 481-5, Jun 2014. DOI: 10.4097/kjae.2014.66.6.481. PMID: 25006375. 
  • A. Ranghino, G. Tognarelli, E. Basso, M. Messina i inni. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.. „Transplant Proc”. 45 (7), s. 2785-7, Sep 2013. DOI: 10.1016/j.transproceed.2013.07.012. PMID: 24034049. 
  • M. Le Quintrec, J. Zuber, B. Moulin, N. Kamar i inni. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.. „Am J Transplant”. 13 (3), s. 663-75, Mar 2013. DOI: 10.1111/ajt.12077. PMID: 23356914. 
  • J. Caprioli, M. Noris, S. Brioschi, G. Pianetti i inni. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.. „Blood”. 108 (4), s. 1267-79, Aug 2006. DOI: 10.1182/blood-2005-10-007252. PMID: 16621965. 
  • A. Hertig, C. Ridel, E. Rondeau. [Hemolytic uremic syndrome in adults].. „Nephrol Ther”. 6 (4), s. 258-71, Jul 2010. DOI: 10.1016/j.nephro.2010.03.002. PMID: 20399168. 
  • M. Noris, S. Bucchioni, M. Galbusera, R. Donadelli i inni. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement.. „J Am Soc Nephrol”. 16 (5), s. 1177-83, May 2005. DOI: 10.1681/ASN.2005010086. PMID: 15800115. 
  • S. Grisaru. Management of hemolytic-uremic syndrome in children.. „Int J Nephrol Renovasc Dis”. 7, s. 231-9, 2014. DOI: 10.2147/IJNRD.S41837. PMID: 24966691. 
  • O. Boyer, P. Niaudet. Hemolytic uremic syndrome: new developments in pathogenesis and treatment.. „Int J Nephrol”. 2011, s. 908407, 2011. DOI: 10.4061/2011/908407. PMID: 21876803. 
  • V. Cheung, H. Trachtman. Hemolytic uremic syndrome: toxins, vessels, and inflammation. „Front Med (Lausanne)”. 1, s. 42, 2014. DOI: 10.3389/fmed.2014.00042. PMID: 25593915. 
  • K. Bláhová, J. Janda, J. Kreisinger, E. Matejková i inni. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.. „Pediatr Nephrol”. 17 (6), s. 400-3, Jun 2002. DOI: 10.1007/s00467-002-0836-z. PMID: 12107802. 
  • AX. Garg, RS. Suri, N. Barrowman, F. Rehman i inni. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.. „JAMA”. 290 (10), s. 1360-70, Sep 2003. DOI: 10.1001/jama.290.10.1360. PMID: 12966129. 
  • J. Lumbreras Fernández, J. Cruz Rojo, G. Iñigo Martín, R. Muley Alonso i inni. [Hemolytic uremic syndrome: long term renal injury].. „An Pediatr (Barc)”. 72 (5), s. 309-16, May 2010. DOI: 10.1016/j.anpedi.2009.12.016. PMID: 20347408. 
  • W. Tang, J. Mohandas, SP. McDonald, CM. Hawley i inni. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.. „BMC Nephrol”. 13, s. 164, 2012. DOI: 10.1186/1471-2369-13-164. PMID: 23206870. 
  • S. Nathanson, T. Kwon, M. Elmaleh, M. Charbit i inni. Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.. „Clin J Am Soc Nephrol”. 5 (7), s. 1218-28, Jul 2010. DOI: 10.2215/CJN.08921209. PMID: 20498239. 
  • K. Takahashi, N. Funata, F. Ikuta, S. Sato. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.. „J Neuroinflammation”. 5, s. 11, 2008. DOI: 10.1186/1742-2094-5-11. PMID: 18355415. 
  • PB. Eisenhauer, MS. Jacewicz, KJ. Conn, O. Koul i inni. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.. „Microb Pathog”. 36 (4), s. 189-96, Apr 2004. DOI: 10.1016/j.micpath.2003.11.004. PMID: 15001224. 
  • Panos GZ., Betsi GI., Falagas ME. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?. „Alimentary pharmacology therapeutics”. 5 (24), s. 731–42, wrzesień 2006. DOI: 10.1111/j.1365-2036.2006.03036.x. PMID: 16918877. 
  • D. Kavanagh, TH. Goodship, A. Richards. Atypical hemolytic uremic syndrome.. „Semin Nephrol”. 33 (6), s. 508-30, Nov 2013. DOI: 10.1016/j.semnephrol.2013.08.003. PMID: 24161037. 
  • GM. Keating. Eculizumab: a review of its use in atypical haemolytic uraemic syndrome.. „Drugs”. 73 (18), s. 2053-66, Dec 2013. DOI: 10.1007/s40265-013-0147-7. PMID: 24249647. 
  • JC. Verhave, JF. Wetzels, NC. van de Kar. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.. „Nephrol Dial Transplant”. 29 (suppl 4), s. iv131-iv141, Sep 2014. DOI: 10.1093/ndt/gfu235. PMID: 25165180. 

dx.doi.org

icm.edu.pl

kbn.icm.edu.pl

nih.gov

ncbi.nlm.nih.gov

  • Corrigan JJ., Boineau FG. Hemolytic-uremic syndrome.. „Pediatrics in review / American Academy of Pediatrics”. 11 (22), s. 365–9, listopad 2001. PMID: 11691946. 
  • Ellen M. Cody, Bradley P. Dixon, Hemolytic Uremic Syndrome, „Pediatric Clinics of North America”, 66 (1), 2019, s. 235–246, DOI: 10.1016/j.pcl.2018.09.011, ISSN 1557-8240, PMID: 30454746 [dostęp 2020-06-11].
  • Maurizio Salvadori, Elisabetta Bertoni, Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations, „World Journal of Nephrology”, 2 (3), 2013, s. 56–76, DOI: 10.5527/wjn.v2.i3.56, ISSN 2220-6124, PMID: 24255888, PMCID: PMC3832913 [dostęp 2020-06-11].
  • Kerstin Benz, Kerstin Amann, Thrombotic microangiopathy: new insights, „Current Opinion in Nephrology and Hypertension”, 19 (3), 2010, s. 242–247, DOI: 10.1097/MNH.0b013e3283378f25, ISSN 1473-6543, PMID: 20186056 [dostęp 2020-06-11].
  • Anagnou NP., Papanicolaou N., Fessas P. Recurrent attacks of hemolytic uremic syndrome.. „Haematologia”. 2 (24), s. 101–5, 1991. PMID: 1816053. 
  • GASSER C., GAUTIER E., STECK A., SIEBENMANN RE., OECHSLIN R. [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia.]. „Schweizerische medizinische Wochenschrift”. 38-39 (85), s. 905–9, wrzesień 1955. PMID: 13274004. 
  • Marina Noris, Giuseppe Remuzzi, Atypical Hemolytic–Uremic Syndrome, „"New England Journal of Medicine"”, 361 (17), 2009, s. 1676–1687, DOI: 10.1056/NEJMra0902814, ISSN 0028-4793, PMID: 19846853 [dostęp 2020-06-11].
  • C. Loirat, V. Frémeaux-Bacchi. Atypical hemolytic uremic syndrome.. „Orphanet J Rare Dis”. 6, s. 60, 2011. DOI: 10.1186/1750-1172-6-60. PMID: 21902819. 
  • SH. Park, GS. Kim. Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.. „Korean J Anesthesiol”. 66 (6), s. 481-5, Jun 2014. DOI: 10.4097/kjae.2014.66.6.481. PMID: 25006375. 
  • A. Ranghino, G. Tognarelli, E. Basso, M. Messina i inni. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.. „Transplant Proc”. 45 (7), s. 2785-7, Sep 2013. DOI: 10.1016/j.transproceed.2013.07.012. PMID: 24034049. 
  • M. Le Quintrec, J. Zuber, B. Moulin, N. Kamar i inni. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.. „Am J Transplant”. 13 (3), s. 663-75, Mar 2013. DOI: 10.1111/ajt.12077. PMID: 23356914. 
  • J. Caprioli, M. Noris, S. Brioschi, G. Pianetti i inni. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.. „Blood”. 108 (4), s. 1267-79, Aug 2006. DOI: 10.1182/blood-2005-10-007252. PMID: 16621965. 
  • A. Hertig, C. Ridel, E. Rondeau. [Hemolytic uremic syndrome in adults].. „Nephrol Ther”. 6 (4), s. 258-71, Jul 2010. DOI: 10.1016/j.nephro.2010.03.002. PMID: 20399168. 
  • M. Noris, S. Bucchioni, M. Galbusera, R. Donadelli i inni. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement.. „J Am Soc Nephrol”. 16 (5), s. 1177-83, May 2005. DOI: 10.1681/ASN.2005010086. PMID: 15800115. 
  • BP. Bell, M. Goldoft, PM. Griffin, MA. Davis i inni. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience.. „JAMA”. 272 (17), s. 1349-53, Nov 1994. PMID: 7933395. 
  • S. Grisaru. Management of hemolytic-uremic syndrome in children.. „Int J Nephrol Renovasc Dis”. 7, s. 231-9, 2014. DOI: 10.2147/IJNRD.S41837. PMID: 24966691. 
  • PC. Rowe, E. Orrbine, H. Lior, GA. Wells i inni. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center.. „J Pediatr”. 132 (5), s. 777-82, May 1998. PMID: 9602185. 
  • O. Boyer, P. Niaudet. Hemolytic uremic syndrome: new developments in pathogenesis and treatment.. „Int J Nephrol”. 2011, s. 908407, 2011. DOI: 10.4061/2011/908407. PMID: 21876803. 
  • V. Cheung, H. Trachtman. Hemolytic uremic syndrome: toxins, vessels, and inflammation. „Front Med (Lausanne)”. 1, s. 42, 2014. DOI: 10.3389/fmed.2014.00042. PMID: 25593915. 
  • K. Bláhová, J. Janda, J. Kreisinger, E. Matejková i inni. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.. „Pediatr Nephrol”. 17 (6), s. 400-3, Jun 2002. DOI: 10.1007/s00467-002-0836-z. PMID: 12107802. 
  • MF. Gagnadoux, R. Habib, MC. Gubler, JL. Bacri i inni. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.. „Clin Nephrol”. 46 (1), s. 39-41, Jul 1996. PMID: 8832149. 
  • AX. Garg, RS. Suri, N. Barrowman, F. Rehman i inni. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.. „JAMA”. 290 (10), s. 1360-70, Sep 2003. DOI: 10.1001/jama.290.10.1360. PMID: 12966129. 
  • RL. Siegler, AT. Pavia, RD. Christofferson, MK. Milligan. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.. „Pediatrics”. 94 (1), s. 35-40, Jul 1994. PMID: 8008534. 
  • J. Lumbreras Fernández, J. Cruz Rojo, G. Iñigo Martín, R. Muley Alonso i inni. [Hemolytic uremic syndrome: long term renal injury].. „An Pediatr (Barc)”. 72 (5), s. 309-16, May 2010. DOI: 10.1016/j.anpedi.2009.12.016. PMID: 20347408. 
  • W. Tang, J. Mohandas, SP. McDonald, CM. Hawley i inni. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.. „BMC Nephrol”. 13, s. 164, 2012. DOI: 10.1186/1471-2369-13-164. PMID: 23206870. 
  • S. Nathanson, T. Kwon, M. Elmaleh, M. Charbit i inni. Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.. „Clin J Am Soc Nephrol”. 5 (7), s. 1218-28, Jul 2010. DOI: 10.2215/CJN.08921209. PMID: 20498239. 
  • A. Roche-Martínez, P. Póo, M. Maristany-Cucurella, A. Jiménez-Llort i inni. [Neurologic presentation in haemolytic-uraemic syndrome].. „Rev Neurol”. 47 (4). s. 191-6. PMID: 18671208. 
  • K. Takahashi, N. Funata, F. Ikuta, S. Sato. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.. „J Neuroinflammation”. 5, s. 11, 2008. DOI: 10.1186/1742-2094-5-11. PMID: 18355415. 
  • PB. Eisenhauer, MS. Jacewicz, KJ. Conn, O. Koul i inni. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.. „Microb Pathog”. 36 (4), s. 189-96, Apr 2004. DOI: 10.1016/j.micpath.2003.11.004. PMID: 15001224. 
  • Panos GZ., Betsi GI., Falagas ME. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?. „Alimentary pharmacology therapeutics”. 5 (24), s. 731–42, wrzesień 2006. DOI: 10.1111/j.1365-2036.2006.03036.x. PMID: 16918877. 
  • D. Kavanagh, TH. Goodship, A. Richards. Atypical hemolytic uremic syndrome.. „Semin Nephrol”. 33 (6), s. 508-30, Nov 2013. DOI: 10.1016/j.semnephrol.2013.08.003. PMID: 24161037. 
  • GM. Keating. Eculizumab: a review of its use in atypical haemolytic uraemic syndrome.. „Drugs”. 73 (18), s. 2053-66, Dec 2013. DOI: 10.1007/s40265-013-0147-7. PMID: 24249647. 
  • JC. Verhave, JF. Wetzels, NC. van de Kar. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.. „Nephrol Dial Transplant”. 29 (suppl 4), s. iv131-iv141, Sep 2014. DOI: 10.1093/ndt/gfu235. PMID: 25165180. 

pubmed.ncbi.nlm.nih.gov

rarediseases.info.nih.gov

web.archive.org

worldcat.org